This version is available at https://strathprints.strath.ac.uk/37915/ Strathprints is designed to allow users to access the research output of the University of Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights for the papers on this site are retained by the individual authors and/or other copyright owners. Please check the manuscript for details of any other licences that may have been applied. You may not engage in further distribution of the material for any profitmaking activities or any commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the content of this paper for research or private study, educational, or not-for-profit purposes without prior permission or charge.Any correspondence concerning this service should be sent to the Strathprints administrator: strathprints@strath.ac.ukThe Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the management and persistent access to Strathclyde's intellectual output. University of Strathclyde, Glasgow G1 1XW, Scotland, UK aaasolyman@Gmail.com,{j.soraghan,stephan}@eee.strath.ac.uk Abstract-The discrete fractional Fourier transform (FrFT) has been suggested to enhance performance over DFT-based multicarrier systems when transmitting over doubly-dispersive channels. In this paper, we propose a novel low-complexity equaliser for inter-symbol and inter-carrier interference arising in such multicarrier transmission system. Due to a lower spreading in the FrFT-domain compared to the DFTchannel matrix as compared to the DFT domain, the equaliser can approximate the fractional-domain channel matrix by a band matrix. Further, we utilise the least squares minres (LSMR) algorithm in the calculation of the equalisation, which exhibits attractive numerical properties and low complexity. Simulation results demonstrate the superior performance of the proposed LSMR equaliser over benchmark schemes. Low-Complexity LSMR Equalisation of FrFT-Based Multicarrier Systems in Doubly Dispersive
Future networks communication scenarios by the 2030s will include notable applications are three-dimensional (3D) calls, haptics communications, unmanned mobility, tele-operated driving, bio-internet of things, and the Nanointernet of things. Unlike the current scenario in which megahertz bandwidth are sufficient to drive the audio and video components of user applications, the future networks of the 2030s will require bandwidths in several gigahertzes (GHz) (from tens of gigahertz to 1 terahertz [THz]) to perform optimally. Based on the current radio frequency allocation chart, it is not possible to obtain such a wide contiguous radio spectrum below 90 GHz (0.09 THz). Interestingly, these contiguous blocks of radio spectrum are readily available in the higher electromagnetic spectrum, specifically in the Terahertz (THz) frequency band. The major contribution of this study is discussing the substantial issues and key features of THz waves, which include (i) key features and significance of THz frequency; (ii) recent regulatory; (iii) the most promising applications; and (iv) possible open research issues. These research topics were deeply investigated with the aim of providing a specific, synopsis, and encompassing conclusion. Thus, this article will be as a catalyst towards exploring new frontiers for future networks of the 2030s.
This article presents an Adaptive Neuro-Fuzzy Inference System (ANFIS) approach to rapidly detect COVID-19 cases using commonly available laboratory blood tests. Current Reverse transcription-polymerase chain reaction (RT-PCR) tests for COVID-19 suffer from several limitations including false-negative results as large as 15-20%, the need for certified laboratories, expensive equipment, and trained personnel; hence the development of an efficient diagnosis system that provides prompt and accurate results is of great importance to control the spread of the virus. Therefore, it was aimed to develop an intelligent system to analyze blood tests and identify significant hematological indicators to support COVID-19 diagnosis. This study interpreted the ANFIS model performance by shapely values to identify the most important and decisive parameters that could assist clinicians in making effective patient management decisions. The findings of this study revealed that WBC (White blood cells) & Platelet counts can act as relevant and significant indicators for the diagnosis of COVID-19 patients. Moreover, the proposed ANFIS model achieved a high prediction accuracy as it was able to discriminate between positive and negative COVID-19 patients with an Accuracy, Sensitivity, and Specificity rates of 95%, 75%, and 97.25% respectively even though 10 % only of the data was positive. Therefore by combining available and low-cost blood test results to analysis based on the ANFIS model, we were able to provide an efficient and robust system to diagnose COVID-19.
The purpose of this study is to develop an accurate risk predictive model for Chronic Myeloid Leukemia (CML) after an early diagnosis of Breast Cancer (BC). Gradient Boosting Machine (GBM) classification algorithm has been applied to the SEER breast cancer dataset for females diagnosed with BC from 2010 to 2016. A practical Swarm optimizer (PSO) was utilized to optimize the GBM algorithm's hyperparameters to find the SEER dataset's best attributes. Nine attributes were carefully selected to study the growth of CML after a lag time of 6 months following BC's diagnosis. The results revealed that the predictive model could classify patients with breast cancer only and patients with breast cancer with Leukemia by an achieved Accuracy, Sensitivity, and Specificity rates of 98.5 %, 99 %, 97.85 %, respectively. To verify the performance of the proposed algorithm, the accuracy of the suggested GBM classifier model was compared with another state-of-the-art model classifiers KNN (k-Nearest Neighbor), SVM (Support Vector Machine), and RF (Random Forest), which are commonly applied algorithms in most of the existing literature. The results also proved the superior ability of the implemented GBM model Classifier in the classification of breast cancer disease and prediction of patients having Leukemia developed after having breast cancer. These results are promising as they show the integral role of the GBM classifier to classify and predict the tumor with high accuracy and efficiency, which will further help in better cancer diagnosis and treatment of the disease.
The sudden increase in patients with severe COVID-19 has obliged doctors to make admissions to intensive care units (ICUs) in health care practices where capacity is exceeded by the demand. To help with difficult triage decisions, we proposed an integration system Xtreme Gradient Boosting (XGBoost) classifier and Analytic Hierarchy Process (AHP) to assist health authorities in identifying patients’ priorities to be admitted into ICUs according to the findings of the biological laboratory investigation for patients with COVID-19. The Xtreme Gradient Boosting (XGBoost) classifier was used to decide whether or not they should admit patients into ICUs, before applying them to an AHP for admissions’ priority ranking for ICUs. The 38 commonly used clinical variables were considered and their contributions were determined by the Shapley’s Additive explanations (SHAP) approach. In this research, five types of classifier algorithms were compared: Support Vector Machine (SVM), Decision Tree (DT), K-Nearest Neighborhood (KNN), Random Forest (RF), and Artificial Neural Network (ANN), to evaluate the XGBoost performance, while the AHP system compared its results with a committee formed from experienced clinicians. The proposed (XGBoost) classifier achieved a high prediction accuracy as it could discriminate between patients with COVID-19 who need ICU admission and those who do not with accuracy, sensitivity, and specificity rates of 97%, 96%, and 96% respectively, while the AHP system results were close to experienced clinicians’ decisions for determining the priority of patients that need to be admitted to the ICU. Eventually, medical sectors can use the suggested framework to classify patients with COVID-19 who require ICU admission and prioritize them based on integrated AHP methodologies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.